Quercetin attenuates oxidative stress in the blood plasma of rats bearing DMBA-induced mammary cancer and treated with a combination of doxorubicin and docetaxel

General Physiology and Biophysics

Volumn 32, Issue 4, 2013, Pages 535-543

  Tabaczar, Sabina ^a   Pieniazek, Anna ^a   Czepas, Jan ^a   Piasecka Zelga, Joanna ^b   Gwoździński, Krzysztof ^a   Koceva Chyła, Aneta ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

Author keywords

Chemotherapy; Docetaxel; Doxorubicin; Flavonoid; Oxidative stress; Quercetin

Indexed keywords

DIMETHYLBENZ[A]ANTHRACENE; DOCETAXEL; DOXORUBICIN; QUERCETIN; SUPEROXIDE DISMUTASE; THIOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; LIPID PEROXIDATION; METABOLIC PARAMETERS; NONENZYMATIC ANTIOXIDANT CAPACITY; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PLASMA; RAT; TUMOR VOLUME;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DOXORUBICIN; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; OXIDATIVE STRESS; QUERCETIN; RATS; RATS, SPRAGUE-DAWLEY; TAXOIDS;

EID: 84893653007     PISSN: 02315882     EISSN: 13384325     Source Type: Journal    
DOI: 10.4149/gpb_2013048     Document Type: Article

References (57)

1. Ameho C. K., Chen C. Y., Smith D., Sánchez-Moreno C., Milbury P. E., Blumberg J. B. (2008): Antioxidant activity and metabolite profile of quercetin in vitamin-E-depleted rats. J. Nutr. Biochem. 19, 467-474 http://dx.doi.org/10.1016/j.jnutbio.2007.06.004
2. Barrera G. (2012): Oxidative stress and lipid peroxidation products in cancer progression and therapy. ISRN Oncol. 2012, 137289
3. Barros A. C., Muranaka E. N., Mori L. J., Pelizon C. H., Iriya K., Giocondo G., Pinotti J. A. (2004): Induction of experimental mammary carcinogenesis in rats with 7,12-dimethylbenz(a)an thracene. Rev. Hosp. Clin. Fac. Med. S. Paulo. 59, 257-261 http://dx.doi.org/10.1590/S0041- 87812004000500006
4. Boesch-Saadatmandi C., Loboda A., Wagner A. E., Stachurska A., Jozkowicz A., Dulak J., Döring F., Wolffram S., Rimbach G. (2011): Effect of quercetin and its metabolites isorhamnetin and quercetin-3-glucuronide on inflammatory gene expression: role of miR-155. J. Nutr. Biochem. 22, 293-299 http://dx.doi.org/10.1016/j.jnutbio.2010.02.008
5. Bournival J., Francoeur M.-A., Renaud J., Martinoli M.-G. (2012): Quercetin and sesamin protect neuronal PC12 cells from highglucose-induced oxidation, nitrosative stress, and apoptosis. Rejuvenation Res. 15, 322-333 http://dx.doi.org/10.1089/rej.2011.1242
6. Camandola S., Poli G., Mattson M. P. (2000): The lipid peroxidation product 4-hydroxy-2,3-nonenal increases AP-1-binding activity through caspase activation in neurons. J. Neurochem. 74, 159-168 http://dx.doi.org/10.1046/j. 1471-4159.2000.0740159.x
7. Chen C. Y., Milbury P. E., Lapsley K., Blumberg J. B. (2005): Flavonoids from almond skins are bioavailable and act synergistically with vitamins C and E to enhance hamster and human LDL resistance to oxidation. J. Nutr. 135, 1366-1373
8. Choi E. J., Bae S. M., Ahn W. S. (2008): Antiproliferative effects of quercetin through cell cycle arrest and apoptosis in human breast cancer MDA-MB-453 cells. Arch. Pharm. Res. 31, 1281-1285 http://dx.doi.org/10.1007/ s12272-001-2107-0
9. Chua P.-J., Yip G. W.-C., Bay B.-H. (2009): Cell cycle arrest induced by hydrogen peroxide is associated with modulation of oxidative stress related genes in breast cancer cells. Exp. Biol. Med. 234, 1086-1094 http://dx.doi.org/10.3181/0903-RM-98
10. da Silva E. L., Piskula M. K., Yamamoto N., Moon J. H., Terao J. (1998): Quercetin metabolites inhibit copper ion-induced lipid peroxidation in rat plasma. FEBS Lett. 430, 405-408 http://dx.doi.org/10.1016/S0014-5793(98)00709-1
11. Ellman G. L. (1959): Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82, 70-77 http://dx.doi.org/10.1016/0003-9861(59)90090-6
12. Ferry D. R., Smith A., Malkhandi J., Fyfe D. W., de Takats P. G., Anderson D., Baker J., Kerr D. J. (1996). Phase I clinical trial of the flavonoid quercetin: Pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin. Cancer Res. 2, 659-668
13. Fischer J. G., Glauert H. P., Yin T., Sweeney-Reeves M. L., Larmonier N., Black M. C. (2002): Moderate iron overload enhances lipid peroxidation in livers of rats, but does not affect NF-kappaB activation induced by the peroxisome proliferator, Wy-14,643. J. Nutr. 132, 2525-2531
14. Gargouri B., Mansour R. B., Abdallah F. B., Elfekih A., Lassoued S., Khaled H. (2011): Protective effect of quercetin against oxidative stress caused by dimethoate in human peripheral blood lymphocytes. Lipids Health Dis. 10, 149 http://dx.doi.org/10.1186/1476-511X-10-149
15. Gay C., Gebicki J. M. (2000): A critical evaluation of the effect of sorbitol on the ferric-xylenol orange hydroperoxide assay. Anal. Biochem. 284, 217-220 http://dx.doi.org/10.1006/abio.2000.4696
16. Hatcher H., Planalp R., Cho J., Torti F. M., Torti S. V. (2008): Curcumin: From ancient medicine to current clinical trials. Cell. Mol. Life Sci. 65, 1631-1652 http://dx.doi.org/10.1007/s00018-008-7452-4
17. Huang J., Zhu M., Tao Y., Wang S., Chen J., Sun W., Li S. (2012): Therapeutic properties of quercetin on monosodium urate crystal-induced inflammation in rat. J. Pharm. Pharmacol. 64, 1119-1127 http://dx.doi.org/10. 1111/j.2042-7158.2012.01504.x
18. Jacobs H., Moalin M., Bast A., van der Vijgh W. J. F., Haenen G. R. (2010): An essential difference between the flavonoids mono-HER and quercetin in their interplay with the endogenous antioxidant network. PLoS One 5, e13880 http://dx.doi.org/10.1371/journal.pone.0013880
19. Ji C., Rouzer C. A., Marnett L. J., Pietenpol J. A. (1998): Induction of cell cycle arrest by the endogenous product of lipid peroxidation, malondialdehyde. Carcinogenesis 19, 1275-1283 http://dx.doi.org/10.1093/carcin/ 19.7.1275
20. Jin F., Nieman D. C., Shanely R. A., Knab A. M., Austin M. D., Sha W. (2010): The variable plasma quercetin response to 12-week quercetin supplementation in humans. Eur. J. Clin. Nutr. 64, 692-697 http://dx.doi.org/10. 1038/ejcn.2010.91
21. Kamaraj S., Vinodhkumar R., Anandakumar P., Jagan S., Ramakrishnan G., Devaki T. (2007): The effects of quercetin on antioxidant status and tumor markers in the lung and serum of mice treated with benzo(a)pyrene. Biol. Pharm. Bull. 30, 2268-2273 http://dx.doi.org/10.1248/bpb.30.2268
22. Klaunig J. E., Wang Z., Pu X., Zhou S. (2011): Oxidative stress and oxidative damage in chemical carcinogenesis. Toxicol. Appl. Pharmacol. 254, 86-99 http://dx.doi.org/10.1016/j.taap.2009.11.028
23. Koceva-Chyla A., Gwozdzinski K., Kochman A., Stolarska A., Jozwiak Z. (2003): Effects of pyrroline and pyrrolidine nitroxides on lipid peroxidation in heart tissue of rats treated with doxorubicin. Cell. Mol. Biol. Lett. 8, 179-183
24. Koceva-Chyła A., Je{ogonek}drzejczak M., Skierski J., Kania K., Jóźwiak Z. (2005): Mechanisms of induction of apoptosis by anthraquinone anticancer drugs aclarubicin and mitoxantrone in comparison with doxorubicin: relation to drug cytotoxicity and caspase-3 activation. Apoptosis 10, 1497-1514 http://dx.doi.org/10.1007/s10495-005-1540-9
25. Kumaraguruparan R., Subapriya R., Kabalimoorthy J., Nagini S. (2002): Antioxidant profile in the circulation of patients with fibroadenoma and adenocarcinoma of the breast. Clin. Biochem. 35, 275-279 http://dx.doi.org/10. 1016/S0009-9120(02)00310-7
26. Lee-Hilz Y. Y., Boerboom A. M., Westphal A. H., Berkel W. J., Aarts J. M., Rietjens I. M. (2006): Pro-oxidant activity of flavonoids induces EpRE-mediated gene expression. Chem. Res. Toxicol. 19, 1499-1505 http://dx.doi.org/10.1021/tx060157q
27. Leonarduzzi G., Arkan M. C., Basaga H., Chiarpotto E., Sevanian A., Poli G. (2000): Lipid oxidation products in cell signaling. Free Radic. Biol. Med. 28, 1370-1378 http://dx.doi.org/10.1016/S0891-5849(00)00216-1
28. Levine R. L., Wehr N., Williams J. A., Stadtman E. R., Shacter E. (2000): Determination of carbonyl groups in oxidized proteins. Meth. Mol. Biol. 99, 15-24
29. Liu W., Kato M., Akhand A. A., Hayakawa A., Suzuki H., Miyata T., Kurokawa K., Hotta Y., Ishikawa N., Nakashima I. (2000): 4-hydroxynonenal induces a cellular redox status-related activation of the caspase cascade for apoptotic cell death. J. Cell Sci. 113, 635-641
30. Lowry O. H., Rosebrough N. G., Farr A. L., Randall R. J. (1951): Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265-275
31. Mahesh T., Menon V. P. (2004): Quercetin alleviates oxidative stress in streptozotocin-induced diabetic rats. Phytother. Res. 18, 123-127 http://dx.doi.org/10.1002/ptr.1374
32. Minotti G., Saponiero A., Licata S., Menna P., Calafiore A. M., Teodori G., Gianni L. (2001): Paclitaxel and docetaxel enhance the metabolism of doxorubicin to toxic species in human myocardium. Clin. Cancer Res. 7, 1511-1515
33. Mir O., Alexandre J., Tran A., Durand J.-P., Pons G., Treluyer J.-M., Goldwasser F. (2009): Relationship between GSTP1 Ile(105)Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicity. Ann. Oncol. 20, 736-740 http://dx.doi.org/10.1093/annonc/mdn698
34. Mira L., Fernandez M. T., Santos M., Rocha R., Florêncio M. H., Jennings K. R. (2002): Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity. Free Radic. Res. 36, 1199-1208 http://dx.doi.org/10.1080/1071576021000016463
35. Misra H., Fridovich I. (1972): The role of superoxide anion in the autooxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem. 247, 3170-3175
36. Misset J. L., Dieras V., Gruia G., Bourgeois H., Cvitkovic E., Kalla S., Bozec L., Beuzeboc P., Jasmin C., Aussel J. P., Riva A., Azli N., Pouillart P. (1999): Dose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancer. Ann. Oncol. 10, 553-560 http://dx.doi.org/10.1023/A:1026418831238
37. Morse D. L., Gray H., Payne C. M., Gillies R. J. (2005): Docetaxel induces cell death through mitotic catastrophe in human breast cancer cells. Mol. Cancer Ther. 4, 1495-1504 http://dx.doi.org/10.1158/1535-7163.MCT-05-0130
38. Murakami A., Ashida H., Terao J. (2008): Multitargeted cancer prevention by quercetin. Cancer Lett. 269, 315-325 http://dx.doi.org/10.1016/j.canlet.2008. 03.046
39. Nabholtz J.-M. A. (2003): Docetaxel-anthracycline combinations in metastatic breast cancer. Breast Cancer Res. Treat. 79 (Suppl. 1), S3-9 http://dx.doi.org/10.1023/A:1024369220605
40. Nam N. H. (2006): Naturally occurring NF-kappaB inhibitors. Mini Rev. Med. Chem. 6, 945-951 http://dx.doi.org/10.2174/138955706777934937
41. Pandey K. B., Rizvi S. I. (2010): Protection of protein carbonyl formation by quercetin in erythrocytes subjected to oxidative stress. Med. Chem. Res. 19, 186-192 http://dx.doi.org/10.1007/s00044-009-9183-y
42. Platel D., Pouna P., Bonoron-Adèle S., Robert J. (2000): Preclinical evaluation of the cardiotoxicity of taxane-anthracycline combinations using the model of isolated perfused rat heart. Toxicol. Appl. Pharmacol. 163, 135-140 http://dx.doi.org/10.1006/taap.1999.8847
43. Psotová J., Chlopčíková Š., Miketová P., Hrbáč J., Šimánek V. (2004): Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes: Part III. Apigenin, baicalelin, kaempherol, luteolin and quercetin. Phytother. Res. 18, 516-521 http://dx.doi.org/10.1002/ptr.1462
44. Reagan-Shaw S., Nihal M., Ahmad N. (2007): Dose translation from animal to human studies revisited. FASEB J. 22, 659-661 http://dx.doi.org/10.1096/fj. 07-9574LSF
45. Rice-Evans C. A., Diplock A. T., Symons M. C. R. (1991): Techniques in free radical research. In:. Laboratory Techniques in Biochemistry and Molecular Biology. (Eds. R. H. Burdon, P. H. Knippenberg), pp. 147-149, Elsevier, Amsterdam
46. Rogalska A., Koceva-Chyła A., Jóźwiak Z. (2008): Aclarubicininduced ROS generation and collapse of mitochondrial membrane potential in human cancer cell lines. Chem. Biol. Interact. 176, 58-70 http://dx.doi.org/10.1016/j.cbi.2008.07.002
47. Rolewski P., Siger A., Nogala-Kałucka M., Polewski K. (2009): Evaluation of antioxidant activity of alpha-tocopherol and quercetin during oxidation of phosphatidylcholine using chemiluminescent detection of lipid hydroperoxides. Pol. J. Food Nutr. Sci. 59, 123-127
48. Salvatorelli E., Menna P., Cascegna S., Liberi G., Calafiore A. M., Gianni L., Minotti G. (2006): Paclitaxel and docetaxel stimulation of doxorubicinol formation in the human heart: implications for cardiotoxicity of doxorubicin-taxane chemotherapies. J. Pharmacol. Exp. Ther. 318, 424-433 http://dx.doi.org/10.1124/jpet.106.103846
49. Santin J. C., Deheinzelin D., Junior S. P., Lopes L. F., de Camargo B. (2007): Late echocardiography assessment of systolic and diastolic function of the left ventricle in pediatric cancer survivors after anthracycline therapy. J. Pediatr. Hematol. Oncol. 29, 761-765 http://dx.doi.org/10.1097/MPH. 0b013e3181580ea2
50. Sawyer D. B., Peng X., Chen B., Pentassuglia L., Lim C. C. (2010): Mechanisms of anthracycline cardiac injury: can we identify strategies for cardioprotection? Prog. Cardiovasc. Dis. 53, 105-113 http://dx.doi.org/10.1016/ j.pcad.2010.06.007
51. Slimestad R., Fossen T., Vågen I. M. (2007): Onions: a source of unique dietary flavonoids. J. Agric. Food Chem. 55, 10067-10080 http://dx.doi.org/10.1021/jf0712503
52. Sokal R. R., Rohlf F. J. (1994): Biometry: The principles and practice of statistics in biological research (3rd edition). (Ed. W. H. Freeman), pp. 272-308, New York
53. Steffen Y., Gruber C., Schewe T., Sies H. (2008): Mono-O-methylated flavanols and other flavonoids as inhibitors of endothelial NADPH oxidase. Arch. Biochem. Biophys. 469, 209-219 http://dx.doi.org/10.1016/j.abb.2007.10.012
54. Yamaguchi T., Takamura H., Matoba T., Terao J. (1998): HPLC method for evaluation of the free radical-scavenging activity of foods by using 1,1-diphenyl-2-picrylhydrazyl. Biosci. Biotechnol. Biochem. 62, 1201-1204 http://dx.doi.org/10.1271/bbb.62.1201
55. Yang Y., Sharma R., Sharma A., Awasthi S., Awasthi Y. C. (2003): Lipid peroxidation and cell cycle signaling: 4-hydroxynonenal, a key molecule in stress mediated signaling. Acta Biochim. Pol. 50, 319-336
56. Zar J. H. (1999): Biostatistical analysis (4th edition). pp. 303-311, Prentice Hall, Upper Saddle River, NJ
57. Zelenka J., Muchova L., Zelenkova M., Vanova K., Vreman H. J., Wong R. J., Vitek L. (2012): Intracellular accumulation of bilirubin as a defense mechanism against increased oxidative stress. Biochimie 94, 1821-1827 http://dx.doi.org/10.1016/j.biochi.2012.04.026